Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01349660
Title Combination of BKM120 and Bevacizumab in Refractory Solid Tumors and Relapsed/Refractory Glioblastoma Multiforme
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors SCRI Development Innovations, LLC
Indications

glioblastoma

Advanced Solid Tumor

Therapies

Bevacizumab + Buparlisib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.